Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. V.K. Magadi Gopalaiah

Research interests

Vinod Kumar leads the immune-genetics and infectious disease research group in identifying the human genes and molecular mechanisms that regulate appropriate immune response to infections, and which may contribute to susceptibility to sepsis and other infectious diseases.

Infections have an enormous impact on human health. My team is interested in deciphering the genetic and molecular mechanisms in disease, particularly infectious diseases. By taking advantage of state-of-the-art technologies and simultaneously assessing genetics and multi-omics in the context of host-pathogen interaction (http://www.humanfunctionalgenomics.org/), we are discovering druggable pathways to treat infectious diseases and developing genetic and genomic biomarkers for precision medicine.

Sepsis, a heterogeneous disorder caused by infections

Sepsis is a major global health problem primarily caused by bacterial and fungal infections. It is a life-threatening disorder characterized by a dysregulated immune response and multi-organ dysfunction. Current strategies using a “one-size-fits-all” treatment approach for sepsis have failed because of the extreme heterogeneity in disease outcome. Factors such as host genetics, pathogens and environmental factors, as well as the unique interaction between these factors in every individual, may contribute to heterogeneity in sepsis. Understanding the impact of these complex interactions on the function of the relevant cell types is therefore crucial to delineating the molecular basis of heterogeneity in outcome.

To do this, we are currently performing systems genetic studies using both patient and population-based cohorts. In particular, we are investigating how genetically determined inter-individual differences in molecular responses to infections contribute to the heterogeneity of fungal and bacterial sepsis outcome. Dissecting the genetic basis of sepsis heterogeneity to infections is a major step towards novel patient-specific therapeutic strategies, which depend on a deep understanding of the molecular interactions between host and pathogens.

Lees meer

Publicaties

Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING

Genetic and nongenetic drivers of platelet reactivity in healthy Tanzanian individuals

Sex-biased genetic regulation of inflammatory proteins in the Dutch population

A functional genomics approach reveals suggestive quantitative trait loci associated with combined TLR4 and BCP crystal-induced inflammation and osteoarthritis

Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patients with severe disease phenotypes

C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection

Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients

Genetic regulators of cytokine responses upon BCG vaccination in children from West Africa

Glutamine Metabolism Supports the Functional Activity of Immune Cells against Aspergillus fumigatus

Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity

Lees meer

Pers/media

Impact of rare and common genetic variation in the interleukin-1 pathway on human cytokine responses